Single-molecule in vitro evolution

• US 20060003347A1
• Filed: 03/11/2005
• Published: 01/05/2006
• Est. Priority Date: 09/11/2002
• Status: Abandoned Application

• Current Assignee: Medical Research Council (Government of United Kingdom)
• Original Assignee: Medical Research Council (Government of United Kingdom)
• Inventors: Griffiths, Andrew, Tawfik, Dan
• Application Number:
  US11/077,956
• Publication Number:
  US 20060003347A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 15/1075 by coupling phenotype to genotype, not provided for in other groups of this subclass

Abstract

The invention relates to a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: a) providing a population of genetic elements and expressing the genetic elements to produce their respective gene product(s), such that each molecule of gene product is linked to the genetic element encoding it at a ratio of one molecule of gene product per genetic element or less; b) compartmentalising the genetic elements into microcapsules; and c) sorting the genetic elements according to the activity of the gene product.

Claims

1. A method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of:

a) providing a population of genetic elements and expressing the genetic elements to produce their respective gene product(s), such that each molecule of gene product is linked to the genetic element encoding it at a ratio of one molecule of gene product per genetic element or less;

b) compartmentalising the genetic elements into microcapsules; and

c) sorting the genetic elements according to the activity of the gene product.

2. A method according to claim 1, wherein in step (b) the activity of the desired gene product within the microcapsule results, directly or indirectly, in the modification of the genetic element encoding the gene product to enable the isolation of the genetic element.

3. A method according to claim 2, wherein a part of the genetic element is a ligand and the desired gene product within the microcapsule binds, directly or indirectly, to said ligand to enable the isolation of the genetic element.

4. A method according to claim 3, wherein the ligand is also encoded by the genetic element.

5. A method according to claim 2, wherein the product of the activity of the desired gene product within the microcapsule results, directly or indirectly, in the generation of a product which is subsequently complexed with the genetic element and enables its isolation.

6. A method according to claim 1, wherein step (a) comprises:

expressing the genetic elements to produce their respective gene products within microcapsules, linking the gene products to the genetic elements encoding them and isolating the complexes thereby formed.

7. A method according to claim 6, wherein the complexes are subjected to a further compartmentalisation step in order to isolate the genetic elements encoding a gene product having the desired activity.

8. A method according to claim 1 further comprising the additional step of:

(d) introducing one or more mutations into the genetic element(s) isolated in step (c).

9. A method according to claim 1 further comprising iteratively repeating one or more of steps (a) to (d).

10. A method according to claim 1 further comprising amplifying the genetic elements.

11. A method according to claim 1, wherein microencapsulation is achieved by forming a water-in-oil emulsion of the aqueous solution in an oil-based medium.

12. A method according to claim 1, wherein the genetic element comprises the gene attached to a microbead.

13. A method according to claim 1, wherein the microbead is nonmagnetic, magnetic or paramagnetic.

14. A method according to claim 1, wherein the genetic elements or microcapsules containing them are sorted by detection of a change in their fluorescence.

15. A method according to claim 14, wherein the sorting of genetic elements or microcapsules is performed using a fluorescence activated cell sorter (FACS).

16. A method according to claim 14, wherein the different fluorescence properties of the substrate and the product are due to fluorescence resonance energy transfer (FRET).

17. A method according to claim 1, wherein the internal environment of the microcapsules is modified by the addition of one or more reagents to the oil phase.

18. A product when isolated according to the method of claim 1.

19. A product according to claim 18 which has a higher activity than an unselected equivalent.

20. A product according to claim 19, which has a higher activity than any pre-existing equivalent.

21. A product according to claim 19, which is a mutant of a hydrolase.

22. A product according to claim 21, which is a mutant of a phosphotriesterase.

23. A phosphotriesterase having a k_cat of 10⁵ s⁻

1 or more.

24. A phosphotriesterase having a k_cat of 2.8×

10⁵ S<sup>−

1</sup>.

25. A phosphotriesterase comprising one or more of the mutations selected from the group consisting of:

I106T and F132L;

I106S, F132L, S308L and Y309R;

I106S;

I106L; and

I106D, W131Y and F132S.

26. A method for preparing a gene product, comprising the steps of:

(a) preparing a genetic element encoding the gene product;

(b) compartmentalising genetic elements into microcapsules;

(c) expressing the genetic elements to produce their respective gene products within the microcapsules and linking the gene products to the genetic elements, such that each genetic element is linked to not more than one molecule of its respective gene product;

(d) sorting the genetic elements which produce the gene product(s) having the desired activity; and

(e) expressing the gene product having the desired activity.

27. A method for screening a compound or compounds capable of modulating the activity of a gene product, comprising the steps of:

(a) preparing a repertoire of genetic elements encoding gene product;

(b) compartmentalising the genetic elements into microcapsules;

(c) expressing the genetic elements to produce their respective gene products within the microcapsules and linking the gene products to the genetic elements, such that each genetic element is linked to not more than one molecule of its respective gene product;

(d) sorting the genetic elements which produce the gene product(s) having the desired activity; and

(e) contacting a gene product having the desired activity with the compound or compounds and monitoring the modulation of an activity of the gene product by the compound or compounds.

28. A method for preparing a compound or compounds comprising the steps of:

(a) providing a synthesis protocol wherein at least one step is facilitated by a polypeptide;

(b) preparing genetic elements encoding variants of the polypeptide which facilitates this step;

(c) compartmentalising the genetic elements into microcapsules;

(d) expressing the genetic elements to produce their respective gene products within the microcapsules and linking the gene products to the genetic elements, such that each genetic element is linked to not more than one molecule of its respective gene product;

(e) sorting the genetic elements which produce polypeptide gene product(s) having the desired activity; and

(f) preparing the compound or compounds using the polypeptide gene product identified in (e) to facilitate the relevant step of the synthesis.